Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00224_DB00361_nanopub.RA4TQK8xmtsdgdx_Oy03qW9RKdXS3luirAIfol3jKyAuw#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00224_DB00361 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00224_DB00361 label "DDI between Indinavir and Vinorelbine - Indinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of Vinorelbine by decreasing its metabolism. Consider alternate therapy to avoid Vinorelbine toxicity. Monitor for changes in the therapeutic and adverse effects of Vinorelbine if Indinavir is initiated, discontinued or dose changed. [drugbank_resource:DB00224_DB00361]" assertion.
- drugbank_resource:DB00224_DB00361 identifier "drugbank_resource:DB00224_DB00361" assertion.
- drugbank_resource:DB00224_DB00361 title "DDI between Indinavir and Vinorelbine - Indinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of Vinorelbine by decreasing its metabolism. Consider alternate therapy to avoid Vinorelbine toxicity. Monitor for changes in the therapeutic and adverse effects of Vinorelbine if Indinavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB00361 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00224_DB00361 assertion.
- drugbank:DB00224 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00224_DB00361 assertion.